Halozyme Therapeutics, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
HALO on Nasdaq
Location
12390 El Camino Real, San Diego, CA

Insiders trading volume in the past year

Halozyme Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Helen Torley PRESIDENT AND CEO, Director $58M -$23.3M -28.7% Nov 10, 2025
Michael J. LaBarre Svp, Chief Technical Officer $12.4M -$1.26M -9.22% Feb 25, 2025
Connie Matsui Director $9.91M Nov 29, 2024
Matthew L. Posard Director $4.46M May 1, 2025
Mark Howard Snyder Svp, Chief Legal Officer $3.62M Jun 12, 2025
Nicole LaBrosse Svp, Chief Financial Officer $3.6M -$1.69M -31.9% Sep 22, 2025
Bernadette Connaughton Director $2.94M -$582K -16.5% Nov 10, 2025
Jean Pierre Bizzari Director $2.56M May 5, 2023
Jeffrey William Henderson Director $1.97M -$1.38M -41.1% May 1, 2025
Akiko Moni Miyashita Director $1.5M May 1, 2025
Barbara Gayle Duncan Director $1.2M May 1, 2025
Masaru Matsuda SVP, General Counsel $1M Sep 4, 2021
James M. Daly Director $896K Aug 11, 2023
Mahesh Krishnan Director $642K May 1, 2025
Cortney Caudill Svp, Chief Operating Officer $563K Oct 3, 2025

Recent Insider Transactions by Companies or Individuals for Halozyme Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.